Trial intelligence / Profile preview

CoGlu: N-Acetylcysteine in Cocaine Addiction

NCT02626494Phase 4Completed

Sponsor
Psychiatrische Universitätsklinik Zürich
Start
Mar 2015
Primary completion
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetylcysteine in cocaine dependence, sponsored by Psychiatrische Universitätsklinik Zürich. Started Mar 2015; status: completed.

02

Drugs

acetylcysteine
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT02626494.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02626494.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call